Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Semi-Quantitative Multiplex Profiling of the Complement System Identifies Associations of Complement Proteins with Genetic Variants and Metabolites in Age-Related Macular Degeneration. | J Pers Med | 2021 | 34945728 | PubTator, text mining | PubMed |
| The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus. | J Clin Med | 2021 | 34945133 | PubTator, text mining | PubMed |
| The Complement System, T Cell Response, and Cytokine Shift in Normotensive versus Pre-Eclamptic and Lupus Pregnancy. | J Clin Med | 2021 | 34945017 | PubTator, text mining | PubMed |
| C4d Deposition after Allogeneic Renal Transplantation in Rats Is Involved in Initial Apoptotic Cell Clearance. | Cells | 2021 | 34944007 | PubTator, text mining | PubMed |
| HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy. | Cells | 2021 | 34943954 | PubTator, text mining | PubMed |
| Protease inhibitor concentrations in the saliva of individuals experiencing oral dryness. | BMC Oral Health | 2021 | 34930236 | PubTator, text mining | PubMed |
| Conformational heterogeneity coupled with β-fibril formation of a scaffold protein involved in chronic mental illnesses. | Transl Psychiatry | 2021 | 34921141 | PubTator, text mining | PubMed |
| NFAT as a Biomarker and Therapeutic Target in Non-Small Cell Lung Cancer-Related Brain Metastasis. | Front Oncol | 2021 | 34917508 | PubTator, text mining | PubMed |
| A Review on Host-Leptospira Interactions: What We Know and Future Expectations. | Front Cell Infect Microbiol | 2021 | 34900757 | PubTator, text mining | PubMed |
| Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein. | Front Immunol | 2021 | 34899688 | PubTator, text mining | PubMed |
| Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection. | Front Microbiol | 2021 | 34899651 | PubTator, text mining | PubMed |
| Enhanced Platelet-Rich Plasma (ePRP) Stimulates Wound Healing through Effects on Metabolic Reprogramming in Fibroblasts. | Int J Mol Sci | 2021 | 34884429 | PubTator, text mining | PubMed |
| Strategies to Modulate the Redifferentiation of Chondrocytes. | Front Bioeng Biotechnol | 2021 | 34881234 | PubTator, text mining | PubMed |
| Two or four injections of platelet-rich plasma for osteoarthritic knee did not change synovial biomarkers but similarly improved clinical outcomes. | Sci Rep | 2021 | 34880370 | PubTator, text mining | PubMed |
| Hemoglobin Precipitation: An Index of In Vitro Vasoconstrictive Activities of Methanol Leaf Extracts of Croton megalocarpus Hutch and Lantana camara Linn. | Evid Based Complement Alternat Med | 2021 | 34876913 | PubTator, text mining | PubMed |
| Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood. | Nat Commun | 2021 | 34876579 | PubTator, text mining | PubMed |
| The Retropepsin-Type Protease APRc as a Novel Ig-Binding Protein and Moonlighting Immune Evasion Factor of Rickettsia. | mBio | 2021 | 34872352 | PubTator, text mining | PubMed |
| Psoriasis to Psoriatic Arthritis: The Application of Proteomics Technologies. | Front Med (Lausanne) | 2021 | 34869404 | PubTator, text mining | PubMed |
| Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to Aspergillus fumigatus Infections. | Front Immunol | 2021 | 34868070 | PubTator, text mining | PubMed |
| COVID-19, Pre-Eclampsia, and Complement System. | Front Immunol | 2021 | 34868042 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=38